NEW ORLEANS — Insomnia was associated with increased risk for MI, especially among older adults and women, according to a meta-analysis presented at the American College of Cardiology Scientific Session.“There have been studies that show that sleep deprivation leads to elevated cortisol which in turn accelerates atherosclerosis, contributing to coronary artery disease and subsequent
NEW ORLEANS — At 3 years, patients with severe aortic stenosis at low surgical risk who had transcatheter aortic valve replacement with a self-expanding valve continued to have lower risk for death or stroke than those who had surgical AVR. In the main results of the Evolut Low Risk Trial, risk for all-cause mortality or disabling stroke at 2 years was numerically lower and noninferior in
NEW ORLEANS — PCI may not improve survival or left ventricular recovery among patients with ischemic cardiomyopathy compared with optimal medical therapy alone, regardless of baseline myocardial viability, a speaker reported. In addition, scar burden, not abundance of dysfunctional-yet-viable segments, was prognostic of LV recovery, independent of baseline LV ejection fraction or CAD
NEW ORLEANS — An automated, patient-specific, electronic health record-embedded tool was associated with increased prescriptions of mineralocorticoid receptor antagonists for patients with HF, the BETTER CARE-HF study showed. Researchers conducted a three-arm, pragmatic, cluster-randomized trial to determine the effectiveness on increasing mineralocorticoid receptor antagonist (MRA)
NEW ORLEANS — In the CLEAR Outcomes trial, bempedoic acid reduced risk for major CV events by 13% compared with placebo, including a 23% lower risk for MI, among adults with a history of CVD or at high risk deemed statin intolerant.Bempedoic acid (Nexletol, Esperion Therapeutics) was FDA approved in 2020 for lowering LDL, but the effects of the drug on CV outcomes have not been assessed,